INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GH
Giancarlo Charles HDirector
ZSZscaler, Inc.
Grant or award
A—
1,076 sh
Jan 12, 2026Jan 13, 2026
Page 1494 of 1814
← PrevNext →
traded Jan 12, 2026
+1d
SEC Form 4

Evidence

9
BK
Buck Kristen KEVP, R&D and CMO
LSTALISATA THERAPEUTICS, INC.
Tax withholding
F$4,230
2,147 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
KH
King-Jones HeidySee Remarks
SYRESpyre Therapeutics, Inc.
Grant or award
A—
140.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
HA
Hanson Eric ACFO
LWAYLifeway Foods, Inc.
Option exercise
M—
1,263 sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
FJ
Fazio JuliePresident of Subsidiary
UGIUGI CORP /PA/
Option exercise
M—
1,350 sh
Jan 11, 2026Jan 13, 2026
traded Jan 11, 2026
+2dSEC Form 4

Evidence

9
HA
Hanson Eric ACFO
LWAYLifeway Foods, Inc.
Option exercise
M—
2,488 sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
RD
Reilly DavidDirector
ALLYAlly Financial Inc.
Grant or award
A$33K
718 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
IT
Imam TariqSVP, Bus Dev, General Counsel
LSTALISATA THERAPEUTICS, INC.
Tax withholding
F$1,472
747 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
IT
Imam TariqSVP, Bus Dev, General Counsel
LSTALISATA THERAPEUTICS, INC.
Grant or award
A—
7,000 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
NR
Niebergall RossDirector
VVXV2X, Inc.
Grant or award
A—
838 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
WA
Wagner Paul A.Director, SEE REMARKS
FBRXForte Biosciences, Inc.
Grant or award
A—
180.0K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

9
DS
Dewan SameerSenior Vice President
GGenpact LTD
Tax withholding · 10b5-1 plan
F$472K
9,780 sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
SD
Schneider DavidDirector
ZSZscaler, Inc.
Grant or award
A—
1,076 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

9
CE
Choi EmiliePresident & COO
COINCoinbase Global, Inc.
Grant or award
A—
160.8K sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
KD
Kornberg Roger D.Director
COCPCocrystal Pharma, Inc.
Grant or award
A—
24.6K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
CE
Choi EmiliePresident & COO
COINCoinbase Global, Inc.
Grant or award
A—
160.8K sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
CE
Choi EmiliePresident & COO
COINCoinbase Global, Inc.
Grant or award
A—
321.6K sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
BG
Bell Hans G.President of Subsidiary
UGIUGI CORP /PA/
Option exercise
M—
3,310 sh
Jan 11, 2026Jan 13, 2026
traded Jan 11, 2026
+2dSEC Form 4

Evidence

9
VL
Vorakoun LisaSVP & CHIEF ACCOUNTING OFFICER
CTOCTO Realty Growth, Inc.
Tax withholding
F$30K
1,635 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

9
BG
Bell Hans G.President of Subsidiary
UGIUGI CORP /PA/
Tax withholding
F$41K
1,118 sh
Jan 11, 2026Jan 13, 2026
traded Jan 11, 2026
+2dSEC Form 4

Evidence

9
FA
Fasano Gerard ADirector
VVXV2X, Inc.
Grant or award
A—
838 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
GG
Galimi Gavin G.SVP, General Counsel & Secr.
EHTHeHealth, Inc.
Tax withholding
F$3,864
966 sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Grant or award
A—
140.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
WA
Wagner Paul A.Director, SEE REMARKS
FBRXForte Biosciences, Inc.
Grant or award
A—
270.0K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

9
TF
Tematio Jean FelixVP, CAO & Corporate Controller
UGIUGI CORP /PA/
Option exercise
M—
2,930 sh
Jan 11, 2026Jan 13, 2026
traded Jan 11, 2026
+2dSEC Form 4

Evidence

9
DD
Doogan DeclanDirector
TENXTENAX THERAPEUTICS, INC.
Grant or award
A—
30.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
BZ
Botelho Kiersten ZazaChief Legal Officer & CCO
HTGCHercules Capital, Inc.
Tax withholding
F$15K
822 sh
Jan 11, 2026Jan 13, 2026
traded Jan 11, 2026
+2dSEC Form 4

Evidence

9
NJ
Nisco JamesSVP, Fin/Treas, Chief Actg Off
LSTALISATA THERAPEUTICS, INC.
Tax withholding
F$1,539
781 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
FC
Follmann ChristianChief Operating Officer
HTGCHercules Capital, Inc.
Tax withholding
F$22K
1,178 sh
Jan 11, 2026Jan 13, 2026
traded Jan 11, 2026
+2dSEC Form 4

Evidence

9
BM
Barbeau Michelle MarieChief Revenue Officer
EHTHeHealth, Inc.
Tax withholding
F$1,516
379 sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
IT
Imam TariqSVP, Bus Dev, General Counsel
LSTALISATA THERAPEUTICS, INC.
Tax withholding
F$2,760
1,401 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
FM
Fong MorganGENERAL COUNSEL & SECRETARY
CARTMaplebear Inc.
Option exercise
M—
10.4K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
SD
Semler DakotaDirector, Chief Executive Officer
XOSXos, Inc.
Tax withholding
F$12K
5,620 sh
Jan 10, 2026Jan 13, 2026
traded Jan 10, 2026
+3dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$344K
2,347 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$481K
3,264 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC Form 4

Evidence

9
FA
Friedman Paul ADirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Option exercise · 10b5-1 plan
M$387K
24.5K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
HR
Hunter RobynDirector
TENXTENAX THERAPEUTICS, INC.
Grant or award
A—
30.0K sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
NJ
Nisco JamesSVP, Fin/Treas, Chief Actg Off
LSTALISATA THERAPEUTICS, INC.
Grant or award
A—
7,000 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
BK
Buck Kristen KEVP, R&D and CMO
LSTALISATA THERAPEUTICS, INC.
Tax withholding
F$5,875
2,982 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence

9
VM
VanHimbergen Robert MEVP and CFO
ELANElanco Animal Health Inc
Grant or award
A$190
8 sh
Jan 9, 2026Jan 13, 2026
traded Jan 9, 2026
+4dSEC Form 4

Evidence